6th Edition of Global Conference on

Pharmaceutics and Novel Drug Delivery Systems

June 13-14, 2022 | Online Event

Biosimilar Market

Biosimilar Market

A biotherapeutic product that is highly comparable to a reference biologic medication is referred to as a biosimilar, also known as a follow-on biologic. It has a complicated molecular structure and is made from living organisms or cells. When a biologic drug's patent expires, firms must seek approval from regulatory authorities before beginning production of biosimilars. Biosimilars are medicines that are primarily made up of proteins that are structurally and functionally similar to biological pharmaceuticals. By 2020, the overall yearly savings gained from the consistent use of biosimilars in meeting expanding public health consumer needs is expected to exceed USD 100 billion. Biosimilar drugs are becoming increasingly popular as a way to cut healthcare expenses.

Committee Members
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Liwu Li

Liwu Li

Virginia Polytechnic Institute and State University, United States
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Sebastien Fortin

Sebastien Fortin

Laval University, Canada
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Vivek Gupta

Vivek Gupta

St. John’s University, United States
PHARMACEUTICS 2022 Speakers
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Pingsheng Liu

Pingsheng Liu

Chinese Academy of Sciences, China
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Ahmet Dogan Ergin

Ahmet Dogan Ergin

Trakya University/Faculty of Pharmacy, Turkey
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Andre Luiz Pereira

Andre Luiz Pereira

Fundacao Hemominas, Brazil
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Gil Goncalves

Gil Goncalves

University of Aveiro, Portugal

Submit your abstract Today

Watsapp